You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ad26COVS1

Showing 1 - 25 of 4,128
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Vienna (Ad26COVS1, ChAdOx1 SARS2 Vaccine, BNT162B2)

Active, not recruiting
  • COVID-19
  • Ad26COVS1
  • +3 more
  • Vienna, Austria
    Medicial University of Vienna
Apr 12, 2022

Covid-19 Prevention Trial in Belgium, United States (Ad26.COV2.S, Placebo)

Active, not recruiting
  • Covid-19 Prevention
  • Ad26.COV2.S
  • Placebo
  • San Diego, California
  • +11 more
Mar 15, 2022

Healthy Trial in Fukuoka-shi, Fukuoka (Ad26.COV2.S, Placebo)

Completed
  • Healthy
  • Ad26.COV2.S
  • Placebo
  • Fukuoka-shi, Japan
  • +2 more
Nov 23, 2021

Coronavirus Disease-2019 (COVID-19) Prevention Trial in Worldwide (Ad26.COV2.S)

Active, not recruiting
  • Coronavirus Disease-2019 (COVID-19) Prevention
  • Ad26.COV2.S
  • Buenos Aires, Argentina
  • +17 more
Jan 17, 2023

Healthy Trial in Worldwide (Ad26.COV2.S, Placebo)

Completed
  • Healthy
  • Ad26.COV2.S
  • Placebo
  • Berlin, Germany
  • +12 more
May 3, 2022

COVID-19 Prevention Trial in Worldwide (Ad26.COV2.S)

Recruiting
  • COVID-19 Prevention
  • Ad26.COV2.S
  • Birmingham, Alabama
  • +48 more
Aug 2, 2022

COVID-19 Prevention Trial in Worldwide (Ad26.COV2.S)

Recruiting
  • COVID-19 Prevention
  • Ad26.COV2.S
  • Little Rock, Arkansas
  • +54 more
Aug 2, 2022

Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 Trial in Worldwide

Active, not recruiting
  • Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19
  • Ad26.COV2.S
  • Placebo
  • Vestavia Hills, Alabama
  • +125 more
Jan 17, 2023

Healthy Trial in United States (Placebo, RSV preF Protein 50 mcg, RSV preF Protein 150 mcg)

Completed
  • Healthy
  • Placebo
  • +8 more
  • Huntsville, Alabama
  • +5 more
Aug 2, 2022

SARS-CoV-2 Infection Trial in Bangkok (Full dose of Ad26.COV2. 5x10^10vp, Half dose of Ad26.COV2. 2.5x10^10vp)

Recruiting
  • SARS-CoV-2 Infection
  • Full dose of Ad26.COV2. 5x10^10vp
  • Half dose of Ad26.COV2. 2.5x10^10vp
  • Bangkok, Thailand
    Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
Sep 11, 2022

Healthy Trial in Rwanda, United States (Ad26.Mos.HIV, Ad26.Mos4.HIV, Clade C gp140)

Completed
  • Healthy
  • Ad26.Mos.HIV
  • +3 more
  • Birmingham, Alabama
  • +9 more
Jul 5, 2022

Ebola Virus Disease Trial in Kambia (Ad26.ZEBOV booster vaccination, given at a dose of 5x10^10 vp, via IM injection)

Active, not recruiting
  • Ebola Virus Disease
  • Ad26.ZEBOV booster vaccination, given at a dose of 5x10^10 vp, via IM injection
  • Kambia, Sierra Leone
    EBOVAC Kambia 1 clinic
Feb 25, 2022

Virus Diseases, Hemorrhagic Fever, Ebola, Infections Trial in Kambia (Ad26.ZEBOV, MVA-BN-Filo)

Recruiting
  • Virus Diseases
  • +10 more
  • Ad26.ZEBOV, MVA-BN-Filo
  • Kambia, Sierra Leone
    EBOVAC Kambia 1 clinic
Oct 11, 2022

Sars-CoV-2 Infection Trial in South Africa (Alveavax-v1.2, Janssen Ad26.COV2.S)

Completed
  • Sars-CoV-2 Infection
  • Bloemfontein, Free State, South Africa
  • +7 more
May 2, 2023

Human Immunodeficiency Virus Trial in Boston (Ad26.Mos4.HIV, MVA-Mosaic, Clade C gp140 + Mosaic gp140)

Completed
  • Human Immunodeficiency Virus
  • Ad26.Mos4.HIV
  • +3 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Feb 7, 2022

Human Immunodeficiency Virus Trial in Bangkok (Ad26.Mos.HIV, MVA-Mosaic, Placebo)

Completed
Has Results
  • Human Immunodeficiency Virus
  • Ad26.Mos.HIV
  • +2 more
  • Bangkok, Thailand
    (unnamed)
Dec 29, 2021

Healthy Trial in Groningen (Ad26.COV2.S)

Completed
  • Healthy
  • Ad26.COV2.S
  • Groningen, Netherlands
    PRA Health Sciences
Dec 21, 2021

HIV, AIDS, Immunologic Deficiency Syndrome, Acquired Trial in Boston (Ad26.Mos4.HIV, MVA-BN-HIV, PGT121)

Recruiting
  • HIV
  • +4 more
  • Ad26.Mos4.HIV
  • +4 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Apr 18, 2022

Oxford-AstraZeneca COVID-19 Vaccine as2nd Booster,

Recruiting
  • COVID-19
  • ChAdOx1 nCOV-19 vaccine (Vaxzeria)
  • +3 more
  • São Paulo, Brazil
    Techtrials Pesquisa e Tecnologia Ltda.
Jan 23, 2023

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

Not yet recruiting
  • Covid-19 Pandemics
  • Tuberculosis
  • Pfizer-BioNTech COVID-19 vaccine
  • +2 more
  • Mae Sot, Tak, Thailand
    Shoklo Malaria Research Unit (SMRU)
Oct 21, 2022

HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

Not yet recruiting
  • HIV-1-infection
  • VRC07-523LS
  • +7 more
  • Pathum Wan, Bangkok, Thailand
  • +1 more
Mar 8, 2023

Human Papillomavirus Infections Trial in Belgium, United States (Ad26.HPV16, Ad26.HPV18, MVA.HPV16/18)

Terminated
Has Results
  • Human Papillomavirus Infections
  • Ad26.HPV16
  • +3 more
  • Doral, Florida
  • +11 more
Nov 23, 2021

HIV-1 Trial in Worldwide (Ad26.Mos4.HIV, Clade C gp140, Placebo)

Completed
  • HIV-1
  • Ad26.Mos4.HIV
  • +2 more
  • Lilongwe, Malawi
  • +22 more
Apr 12, 2022

Transverse Myelitis Related to SARS-CoV-2 Vaccines

Completed
  • Vaccine Adverse Reaction
  • SARS-CoV-2 vaccines
  • Caen, Basse Normandie, France
    Alexandre Joachim
Jan 3, 2022

EBOVAC-Salone Extension

Active, not recruiting
  • Ebola Virus Disease
  • Follow-up
  • Blood sample collection
  • Rokupr, Kambia, Sierra Leone
  • +1 more
Feb 25, 2022